November 15, 2026
Breaking News
  • Trump, Xi and Putin Summit: 5 Key Issues Shaping Global Geopolitics
  • Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply
  • Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%
  • Nvidia governance crisis deepens as new details emerge about former CEO
B2Bmarketsignal B2Bmarketsignal
Nav
  • Home
  • Breaking News
  • Automotive
  • Energy
  • Healthcare
  • Technology
  • Transport & Logistics
  • Features
  • Companies
  • Contact Us
B2Bmarketsignal
Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features November 14, 2026

Trump, Xi and Putin Summit: 5

Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare November 14, 2026

Pfizer Premarin Discontinuation Adds Pressure to

Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy November 14, 2026

Canada’s C$200m Woodfibre LNG Investment to

Nvidia
Technology November 14, 2026

Nvidia governance crisis deepens as new

  • Home
  • Breaking News
  • Automotive
  • Energy
  • Healthcare
  • Technology
  • Transport & Logistics
  • Features
  • Companies
  • Contact Us
  1. Home
  2. Healthcare
Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare

Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply

Pfizer Canada told Reuters that the vaginal cream had been in short supply since June and that no further batches...
  • BY admin
  • November 14, 2026
  • 0 Comment
Temple Brain Tracker: Doctors Question $900 Wearable
Healthcare

Temple Brain Tracker: Doctors Question $900 Wearable’s Claims

Deepinder Goyal’s Temple wearable is facing scrutiny from Indian doctors over its claims of monitoring blood circulation to the brain,...
  • BY admin
  • November 12, 2026
  • 0 Comment
Innate Pharma to Present IPH4502 Phase 1 Data on 18 November 2026
Healthcare

Innate Pharma to Present IPH4502 Phase 1 Data on November...

Innate Pharma will present clinical development findings for IPH4502, its investigational Nectin-4 antibody-drug conjugate (ADC), at an in-person and virtual...
  • BY admin
  • November 11, 2026
  • 0 Comment
GLP-1 weight-loss and diabetes medicines linked to new FDA eye-risk warnings.
Healthcare

FDA Adds GLP-1 Eye-Risk Warning After Reviewing 126 Clinical Trials

The US Food and Drug Administration (FDA) has ordered manufacturers of glucagon-like peptide-1 (GLP-1) medicines to update their product labelling...
  • BY admin
  • November 10, 2026
  • 0 Comment
Novartis and Novo Nordisk Drug Trials Fail in 2026
Healthcare

Novartis and Novo Nordisk cardiovascular drug trials fail in 2026

Two experimental cardiovascular drugs developed by Novartis and Novo Nordisk have failed to demonstrate a reduction in major heart-related events...
  • BY admin
  • November 9, 2026
  • 0 Comment
Johnson & Johnson secures FDA approval for Rybrevant Faspro head and neck cancer treatment.
Healthcare

J&J wins FDA approval for Rybrevant Faspro after 42% tumour...

Johnson & Johnson has secured accelerated approval from the US Food and Drug Administration (FDA) for its cancer treatment Rybrevant...
  • BY admin
  • November 7, 2026
  • 0 Comment
AstraZeneca's $10bn Rhythm Bid: 5 Key Deal Details
Healthcare

AstraZeneca Makes $10bn Offer for Obesity Drugmaker Rhythm Pharmaceuticals

AstraZeneca has made a non-binding offer worth approximately US$10 billion to acquire US-based Rhythm Pharmaceuticals, in a move that could...
  • BY admin
  • November 6, 2026
  • 0 Comment
CVS Health Split: Pharmacy and Insurance Separation by 2028
Healthcare

CVS Health to Split Pharmacy and Insurance Businesses in Major...

CVS Health plans to separate its retail pharmacy operations from its health insurance, pharmacy benefit management and healthcare services businesses,...
  • BY admin
  • November 6, 2026
  • 0 Comment
Dr Reddy's Generic Ozempic Gets Brazil Approval
Healthcare

Dr Reddy’s Wins Brazil Approval for Generic Ozempic

Indian pharmaceutical company Dr Reddy’s Laboratories has secured regulatory approval in Brazil to market its generic semaglutide injection, opening another...
  • BY admin
  • November 5, 2026
  • 1 Comment
CVS Health Breakup: Pharmacy and Insurance Split
Healthcare

CVS Health plans to split pharmacy and insurance businesses into...

CVS Health is planning to separate its retail pharmacy operations from its health insurance and pharmacy benefit management businesses, potentially...
  • BY admin
  • November 4, 2026
  • 0 Comment
  • 1
  • 2
  • 3

Recent News

Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features

Trump, Xi and Putin Summit: 5 Key Issues Shaping Global Geopolitics

  • November 14, 2026
Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare

Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply

  • November 14, 2026
Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy

Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%

  • November 14, 2026

Blog Posts

Trump Xi Putin summit in China during the 2026 APEC meeting.
Technology Features November 14, 2026

Trump, Xi and Putin Summit: 5 Key Issues Shaping Global

Pfizer discontinues Premarin hormone therapy products in Canada amid menopause drug supply shortages.
Healthcare November 14, 2026

Pfizer Premarin Discontinuation Adds Pressure to Canada’s Menopause Drug Supply

Woodfibre LNG export facility under construction near Squamish, British Columbia, Canada.
Energy November 14, 2026

Canada’s C$200m Woodfibre LNG Investment to Lift Capacity by 24%

Nvidia
Technology November 14, 2026

Nvidia governance crisis deepens as new details emerge about former

  1. B2B Market Signal delivers the latest business news, market insights, industry trends, and expert perspectives to help businesses stay informed and ahead.
  • admin@b2bmarketsignal.com

Quick links

  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
Follow Us:

© 2026 B2B Marketsignal. All Rights Reserved.Powered by SHRICLOUD.